- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2010
- Public Summary Document (PSD) March 2010 PBAC Meeting - PDF
Cetuximab – March 2010
Cetuximab, solution for IV infusion, 100 mg in 20 mL, 100 mg in 50 mL and 500 mg in 100 mL, Erbitux® - March 2010
Last updated
16 July 2010